David Goldstein, Chief Scientific Officer at Principia Biopharma Inc. (PRNB), sold 6,000 shares at $69.53 ($425K) on 2020-02-10, disclosed to the SEC on 2020-02-12.
Open-market sale of $425k PRNB by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.53 | 800 | $56K | 13.1% |
| 2 | $71.11 | 5,200 | $370K | 86.9% |
| Total | $70.90 avg | 6,000 | $425K | 100% |